Author

Jorge Antonio Elias Godoy Carlos

Universidade de São PauloORCID 0000-0002-2833-4665Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Cleber Camilo Melo-FilhoiD· 1 shared Eugene N. MuratoviD· 1 shared Holli‐Joi MartiniD· 1 shared João Agostinho Machado‐NetoiD· 1 shared Karoline B. WaitmaniD· 1 shared Letícia Veras Costa-LotufoiD· 1 shared Maurício T. TavaresiD· 1 shared Mike SchutkowskiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Cleber Camilo Melo-FilhoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dona Flor and her two husbands: Discovery of novel HDAC6/AKT2 inhibitors for myeloid cancer treatment

Karoline B. Waitman, Holli‐Joi Martin, Jorge Antonio Elias Godoy Carlos, Rodolpho C. Braga, Vinícius A.M. Souza, Cleber Camilo Melo-Filho, Sebastian Hilscher, Mônica F. Z. J. Toledo, Maurício T. Tavares, Letícia Veras Costa-Lotufo, João Agostinho Machado‐Neto, Mike Schutkowski, Wolfgang Sippl, Thales Kronenberger, Vinícius M. Alves, , Eugene N. Muratov

The paper uses machine learning to identify novel HDAC6/AKT2 inhibitors for myeloid cancer treatment, finding compounds with potent anticancer activity.

Computers in Biology and Medicine · Dec 5, 2024Peer-reviewedCancer Biology